eli lilly's tirzepatide is the leader in weight loss sector weight-loss drug reduces sleep apnea severity late-stage trials China Clears Eli Lilly's Weight

So make sure you discuss your options with a licensed medical professional

There were no significant differences between tirzepatide 5 mg and semaglutide 2 mg in change from baseline in HbA1c at week 40 with an ETD of 0.07% (95% CI 0.2, 0.34

These real-world findings provide insights into the effectiveness and tolerability of these medications outside the controlled environment of RCTs, reinforcing the potential of tirzepatide as a highly effective option for weight management in routine clinical practice

On average, tirzepatide has been shown in research to lead to a greater amount of weight loss : People with obesity in clinical trials for tirzepatide lost, on average, 20% of their body weight at week 72 (and about 7 inches off their waistlines), compared with about 14% of their body weight (and about 5 inches off their waistlines) with semaglutide

It tends to be easier on the gastrointestinal system and offers an oral option (Rybelsus) for those who prefer to avoid injections

Semaglutide is a GLP-1 receptor agonist